Advanced search
Publication Cover
Hematology Volume 11, 2006 - Issue 1
Submit an article Journal homepage
192
Views
20
CrossRef citations to date
0
Altmetric
Current Clinical Practice

The genetics of the myelodysplastic syndromes: Classical cytogenetics and recent molecular insights

Sindhu CherianDepartment of Laboratory MedicineUniversity of Washington Medical Center, Seattle, WA, USA
&
Adam BaggDepartment of PathologyLaboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
Pages 1-13 | Published online: 29 Nov 2013

Citations (20)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Joyce J Ou & Adam Bagg. (2009) Diagnostic challenges in the myelodysplastic syndromes: the current and future role of genetic and immunophenotypic studies. Expert Opinion on Medical Diagnostics 3:3, pages 275-291.
Read now

Articles from other publishers (19)

Susan Mahler Zneimer. 2014. Cytogenetic Abnormalities. Cytogenetic Abnormalities 357 393 .
Heidrun Karlic, Harald Herrmann, Franz Varga, Roman Thaler, Rene Reitermaier, Silvia Spitzer, Viviane Ghanim, Katharina Blatt, Wolfgang R. Sperr, Peter Valent & Michael Pfeilstöcker. (2014) The role of epigenetics in the regulation of apoptosis in myelodysplastic syndromes and acute myeloid leukemia. Critical Reviews in Oncology/Hematology 90:1, pages 1-16.
Crossref
Yan Zeng, Xin Duan, Dan Long, Ruiqing Zhou & Songtao Yang. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Yan Zeng, Xin Duan, Dan Long, Ruiqing Zhou & Songtao Yang. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Maryalice Stetler‐Stevenson, Joseph A. DiGiuseppe & Diane C. Arthur. 2012. Laboratory Hematology Practice. Laboratory Hematology Practice 331 344 .
Shane A. Gangatharan, Dennis A. Carney, Lynda J. Campbell, H. Miles Prince, Melita K. Kenealy & John F. Seymour. (2011) Cytogenetic response is not a prerequisite for clinical response in patients with myelodysplastic syndromes treated with azacitidine. European Journal of Haematology 87:2, pages 186-188.
Crossref
Wing C. (John) Chan, Timothy C. Greiner & Adam Bagg. 2011. Hematopathology. Hematopathology 56 80 .
James Huang & Richard D. Press. 2011. Essentials of Anatomic Pathology. Essentials of Anatomic Pathology 489 513 .
Dolors Costa, Sandra Valera, Ana Carrió, Amparo Arias, Concha Muñoz, María Rozman, Mohamed Belkaid, Rita Coutinho, Benet Nomdedeu & Elias Campo. (2010) Do we need to do fluorescence in situ hybridization analysis in myelodysplastic syndromes as often as we do?. Leukemia Research 34:11, pages 1437-1441.
Crossref
Hagop M. KantarjianFrancis J. GilesPeter L. GreenbergRon L. PaquetteEunice S. WangJanice L. Gabrilove, Guillermo Garcia-ManeroKuolung Hu, Janet L. Franklin & Dietmar P. Berger. (2010) Phase 2 study of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving azacitidine therapy. Blood 116:17, pages 3163-3170.
Crossref
Y. Ma, X. Wang, X. Xu & G. Lin. (2009) Prognostic value of trisomy 8 in primary myelodysplastic syndrome. Internal Medicine Journal 40:10, pages 697-703.
Crossref
Ulrike Bacher, Claudia Haferlach, Nicolaus Kröger, Susanne Schnittger, Wolfgang Kern, Bettina Wiedemann, Axel Rolf Zander & Torsten Haferlach. (2010) Diagnostic Tools in the Indications for Allogeneic Stem Cell Transplantation in Myelodysplastic Syndromes. Biology of Blood and Marrow Transplantation 16:1, pages 1-11.
Crossref
Jo-Anne Vergilio & Adam Bagg. 2009. Molecular Pathology in Clinical Practice: Oncology. Molecular Pathology in Clinical Practice: Oncology 213 226 .
Claudia Haferlach, Ulrike Bacher, Ramon Tiu, Jaroslaw P. Maciejewski & Alan List. (2008) Myelodysplastic syndromes with del(5q): indications and strategies for cytogenetic testing. Cancer Genetics and Cytogenetics 187:2, pages 101-111.
Crossref
Daniel T. StarczynowskiSuzanne VercauterenAdele TeleniusSandy SungKaoru TohyamaAngela Brooks-WilsonJohn J. Spinelli, Connie J. Eaves, Allen C. Eaves, Douglas E. HorsmanWan L. Lam & Aly Karsan. (2008) High-resolution whole genome tiling path array CGH analysis of CD34+ cells from patients with low-risk myelodysplastic syndromes reveals cryptic copy number alterations and predicts overall and leukemia-free survival. Blood 112:8, pages 3412-3424.
Crossref
Faramarz Naeim, P. Nagesh Rao & Wayne W. Grody. 2008. Hematopathology. Hematopathology 129 154 .
Jin-Yeong Han & Karl Theil. (2007) Karyotypic Identification of Abnormal Clones Preceding Morphological Changes or Occurring with No Definite Morphological Features of Myelodysplastic Syndrome: A Preliminary Study. Laboratory Hematology 13:1, pages 17-21.
Crossref
Jo-Anne Vergilio & Adam Bagg. 2007. Molecular Pathology in Clinical Practice. Molecular Pathology in Clinical Practice 383 396 .
. (2006) Current Awareness in Hematological Oncology. Hematological Oncology 24:3, pages 166-173.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.